• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMC 0.00% 10.0¢

IMMURON LIMITED

Immuron Limited is an Australia-based biopharmaceutical company focused on developing and... Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects in Australia, Israel and the United States. The Company's flagship commercial products consist of Travelan and Protectyn. Travelan is an over the counter orally administered passive immunotherapeutic product indicated to reduce the risk of travelers' diarrhea, reduce the risk of minor gastro-intestinal disorders and is antimicrobial. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. The Company has four clinical programs -Travelan (IMM-124E), CampETEC, IMM-529 and Travelan (consumer product).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IMC
Company presenting on LIVE & FREE webinar TOMORROW (Tuesday) @ 10am AWST
12:55 1 343
12:55 Last post  goolop27 Comments Created with Sketch.  1  Views Created with Sketch.  343 
IMC 12:30 1 196
12:30 Last post  ich Comments Created with Sketch.  1  Views Created with Sketch.  196 
IMC 25/04/24 3 1.0K
25/04/24 Last post  goolop27 Comments Created with Sketch.  3  Views Created with Sketch.  1.0K 
IMC
Banter and General Comments
22/04/24 26 8.4K
22/04/24 Last post  davide1 Comments Created with Sketch.  26  Views Created with Sketch.  8.4K 
IMC 15/04/24 0 311
15/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  311 
IMC
News: IMC Immuron Says Fytd Mar 2024 Global Travelan Sales A$3.6 Million, Up 154%
12/04/24 2 804
12/04/24 Last post  garywho Comments Created with Sketch.  2  Views Created with Sketch.  804 
IMC 11/04/24 11 2.9K
11/04/24 Last post  Misterf Comments Created with Sketch.  11  Views Created with Sketch.  2.9K 
IMC 28/03/24 164 45K
28/03/24 Last post  davide1 Comments Created with Sketch.  164  Views Created with Sketch.  45K 

See All Discussions arrow Created with Sketch.

Timeline

Change in substantial holding
30 Apr 08:23
 
Immuron CEO Steven Lydeamore to present at The Watchlist
23 Apr 09:17
 
Immuron to host Live Virtual Event
15 Apr 10:34
 
Immuron Travelan sales continued strong growth
10 Apr 09:00
 
Change in substantial holding
22 Mar 08:24
 
Notice under section 708A
14 Mar 10:53
 
View More arrow Created with Sketch.
(20min delay)
Last
10.0¢
Change
0.000(0.00%)
Mkt cap ! $22.8M
Open High Low Value Volume
10.0¢ 10.0¢ 9.9¢ $16.68K 166.8K

Buyers (Bids)

No. Vol. Price($)
1 29183 9.9¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 249372 10
View Market Depth
Last trade - 15.40pm 30/04/2024 (20 minute delay) ?
Last
10.0¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
10.0¢ 10.0¢ 10.0¢ 45446
Last updated 15.40pm 30/04/2024 ?
IMC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.